JG
ROIV icon

Joel Greenblatt’s Roivant Sciences ROIV Stock Holding History

Joel Greenblatt’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8M Sell
1,349,465
-66,626
-5% -$1.97M 0.11% 204
2026
Q1 		$39.2M Buy
1,416,091
+490,898
+53% +$12.6M 0.12% 188
2025
Q4 		$20.1M Buy
925,193
+594,718
+180% +$11.7M 0.07% 387
2025
Q3 		$5M Buy
330,475
+291,326
+744% +$3.61M 0.02% 778
2025
Q2 		$441K Buy
39,149
+122
+0.3% +$1.32K ﹤0.01% 1358
2025
Q1 		$394K Hold
39,027
– – ﹤0.01% 1297
2024
Q4 		$462K Hold
39,027
– – ﹤0.01% 1146
2024
Q3 		$450K Sell
39,027
-510
-1% -$5.81K ﹤0.01% 1138
2024
Q2 		$418K Buy
+39,537
New +$433K 0.01% 1129

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Joel Greenblatt's ROIV Position: Q2 2026 in Review

Joel Greenblatt reduced its Roivant Sciences (ROIV) stake by 4.7% in Q2 2026, selling an estimated $1.97M and leaving 1,349,465 shares worth $47.8M. The position accounts for 0.11% of the portfolio, ranked #204.

Joel Greenblatt first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. 495 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Joel Greenblatt held 1,349,465 shares of Roivant Sciences worth $47.8M as of Q2 2026.
  • Joel Greenblatt sold 66,626 Roivant Sciences shares in Q2 2026, an estimated $1.97M.
  • Roivant Sciences made up 0.11% of Joel Greenblatt's portfolio in Q2 2026, its #204 holding.
  • Joel Greenblatt first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
  • 495 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.